Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.
J Comp Eff Res. 2022 Nov;11(16):1173-1184. doi: 10.2217/cer-2022-0111. Epub 2022 Sep 23.
J Comp Eff Res. 2022.
PMID: 36148923
Free article.
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban.
Marín F, Fernández MS, Barón-Esquivias G, Barrios V, Lekuona I, Pérez-Cabeza AI, Masjuan J, Del Vigo ER, Vázquez Rodríguez JM, Freixa-Pamias R, Schilling VR, Arribas F, Priu CR, Sánchez MA.
Marín F, et al. Among authors: schilling vr.
J Comp Eff Res. 2023 Mar;12(3):e220049. doi: 10.57264/cer-2022-0049. Epub 2023 Feb 7.
J Comp Eff Res. 2023.
PMID: 36749006
Free PMC article.
Item in Clipboard
Comments on the 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.
SEC Working Group for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism; Expert Reviewers for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism; SEC Clinical Practice Guidelines Committee.
SEC Working Group for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism, et al.
Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):10-6. doi: 10.1016/j.rec.2014.11.003.
Rev Esp Cardiol (Engl Ed). 2015.
PMID: 25553936
No abstract available.
Item in Clipboard
Cite
Cite